Skip to content

pain DETECT : a new screening questionnaire to identify neuropathic components in patients with back pain

Rainer Freynhagen, Ralf Baron, Ulrich Gockel, Thomas Rudolf Tölle

Current Medical Research and Opinion · 2006 · 2,353 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Freynhagen, R., Baron, R., Gockel, U., & Tölle, T. R. (2006). pain DETECT : a new screening questionnaire to identify neuropathic components in patients with back pain. Current Medical Research and Opinion, 22(10), 1911–1920. https://doi.org/10.1185/030079906x132488

In text: (Freynhagen et al., 2006)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

OBJECTIVE: Nociceptive and neuropathic components both contribute to pain. Since these components require different pain management strategies, correct pain diagnosis before and during treatment is highly desirable. As low back pain (LBP) patients constitute an important subgroup of chronic pain patients, we addressed the following issues: (i) to establish a simple, validated screening tool to detect neuropathic pain (NeP) components in chronic LBP patients, (ii) to determine the prevalence of neuropathic pain components in LBP in a large-scale survey, and (iii) to determine whether LBP patients with an NeP component suffer from worse, or different, co-morbidities. METHODS: In co-operation with the German Research Network on Neuropathic Pain we developed and validated the painDETECT questionnaire (PD-Q) in a prospective, multicentre study and subsequently applied it to approximately 8000 LBP patients. RESULTS: The PD-Q is a reliable screening tool with high sensitivity, specificity and positive predictive accuracy; these were 84% in a palm-top computerised version and 85%, 80% and 83%, respectively, in a corresponding pencil-and-paper questionnaire. In an unselected cohort of chronic LBP patients, 37% were found to have predominantly neuropathic pain. Patients with NeP showed higher ratings of pain intensity, with more (and more severe) co-morbidities such as depression, panic/anxiety and sleep disorders. This also affected functionality and use of health-care resources. On the basis of given prevalence of LBP in the general population, we calculated that 14.5% of all female and 11.4% of all male Germans suffer from LBP with a predominant neuropathic pain component. CONCLUSION: Simple, patient-based, easy-to-use screening questionnaires can determine the prevalence of neuropathic pain components both in individual LBP patients and in heterogeneous cohorts of such patients. Since NeP correlates with more intense pain, more severe co-morbidity and poorer quality of life, accurate diagnosis is a milestone in choosing appropriate therapy.

  1. The MOS 36-ltem Short-Form Health Survey (SF-36)1992
  2. The Pain Catastrophizing Scale: Development and validation.1995
  3. The McGill Pain Questionnaire: Major properties and scoring methods1975
  4. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee1986
  5. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis1995

Metadata from OpenAlex (CC0). Citations are generated from the published record.